| DC Field | Value | Language |
|---|
| dc.contributor.author | Patrakhanov, E. A. | - |
| dc.contributor.author | Kuzubova, E. V. | - |
| dc.contributor.author | Zhunusov, N. S. | - |
| dc.contributor.author | Radchenko, A. I. | - |
| dc.contributor.author | Kurdyukov, V. Y. | - |
| dc.contributor.author | Denisova, A. R. | - |
| dc.contributor.author | Avramenko, A. A. | - |
| dc.contributor.author | Pokrovskii, M. V. | - |
| dc.date.accessioned | 2026-10-13T08:50:14Z | - |
| dc.date.available | 2026-10-13T08:50:14Z | - |
| dc.date.issued | 2026 | - |
| dc.identifier.citation | HAEE tetrapeptide as a promising neuroprotector: comparison with Piracetam in an experimental model of Alzheimer's disease / E.A. Patrakhanov, E.V. Kuzubova, N.S. Zhunusov [et al.] // Research Results in Pharmacology. - 2026. - Vol.12, №3.-P. 72-90. - DOI: 10.18413/rrpharmacology.12.1179. - Refer.: p. 89. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/67141 | - |
| dc.description.abstract | The administration of HAEE and Piracetam led to an improvement in cognitive performance, with both groups demonstrating memory recovery to the level of intact controls. Histological analysis showed an increase in the number of amyloid plaques in the positive control animals and a reduction in the therapeutic groups by an average of 40% | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | alzheimer's disease | ru |
| dc.subject | beta-amyloid | ru |
| dc.subject | behavioral testing | ru |
| dc.subject | gene expression | ru |
| dc.title | HAEE tetrapeptide as a promising neuroprotector: comparison with Piracetam in an experimental model of Alzheimer's disease | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 12, № 3
|
